Wearable Cortisol Patches Offer Real-Time Stress Monitoring Outside the Lab
New wearable patches from companies including Adaptyx Biosciences and EnLiSense can now track cortisol levels continuously from interstitial fluid and sweat, giving users real-time data on stress and circadian rhythms. Adaptyx presented first-in-human data at the American Diabetes Association meeting in June 2026.
Wearable patches that continuously track cortisol levels are moving from research labs toward consumer and clinical use, offering a new way to monitor stress, sleep, and circadian rhythms outside of traditional medical settings.
Adaptyx Biosciences has developed a wearable patch that uses synthetic DNA-based molecular switches called aptamers to provide continuous, real-time measurements of free cortisol from interstitial fluid. The patch measures cortisol levels minute-by-minute, capturing natural rhythms such as the cortisol awakening response. The company presented first-in-human data at the American Diabetes Association meeting in June 2026 and is pursuing an FDA Class II regulatory pathway. The platform is being developed for clinical applications including the management of rare adrenal disorders and hard-to-control type 2 diabetes.
EnLiSense offers a separate product called CORTI, a wearable patch that tracks cortisol and melatonin in sweat. The device is marketed for general wellness, including monitoring sleep patterns and stress, rather than medical diagnosis. It uses passive-sweat sensor technology and provides biomarker data through the SWEAT AWARE app. As of January 2026, EnLiSense products are positioned as low-risk general wellness devices under FDA guidance.
A study published in January 2026 introduced a paper-based microfluidic platform using gold-nanoflower-based assays to monitor cortisol in sweat, demonstrating the ability to resolve circadian variations and acute stress responses.
The broader health and wellness sector is increasingly centered on consumers who use technology to manage their health outside of traditional clinical settings. Major tech companies including OpenAI and Microsoft have launched health-specific tools to assist users in navigating care, while wearable devices are evolving to incorporate more sophisticated biological data.
